YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Adderall
FDA orders warning 'guides' for ADHD drugs
Feb 21, 2007 | USA Today
Pharmacists will soon begin handing out consumer-friendly "medication guides" about cardiovascular and psychiatric problems linked to...
FDA Directs ADHD Drug Manufacturers to Notify Patients about Cardiovascular Adverse Events and Psychiatric Adverse Event
Feb 21, 2007 | www.fda.gov
The U.S. Food and Drug Administration (FDA) today directed the manufacturers of all drug products approved for the treatment of Attention Deficit...
Study: ADHD drugs send thousands to ERs
May 24, 2006 | AP
Accidental overdoses and side effects from attention deficit drugs likely send thousands of children and adults to emergency rooms, according to the...
Ped Med: ADHD in the very young
Feb 16, 2006 | UPI
Discerning behavior that portends attention-deficit/hyperactivity disorder presents challenges during the highly volatile first years of...
FDA Advisory Committee Recommends 'Black Box' Warning for Ritalin, Adderall, Concerta, and Other ADHD Drugs for Potential Risk of Heart Attacks, Strokes, and Sudden Death
Feb 10, 2006 | Newsinferno News Staff
In what many experts are viewing as an unusual turn of events, an FDA advisory panel has voted to recommend that the agency order the inclusion of...
ADHD pills need warning, panel says
Feb 10, 2006 | Los Angeles Times
A Food and Drug Administration advisory panel Thursday urged that the strongest-possible safety warning be issued for drugs used by millions of...
Feds Consider Warnings on ADHD Drugs
Feb 9, 2006 | AP
Federal health advisers considered on Thursday whether warning labels might be needed on drugs for attention deficit hyperactivity disorder following...
Feds Recommend Warnings on ADHD Drugs
Feb 9, 2006 | AP
Federal science advisers voted narrowly Thursday to recommend the most serious type of warning labels for Ritalin and other stimulants that are used...
Drug under scrutiny
Feb 2, 2006 | Newsday
A hyperactivity drug linked last year to deaths, strokes and heart attacks in dozens of patients is expected to face new scrutiny next week when a...
FDA to probe ADHD drug safety
Jan 5, 2006 | Pharma Times
The US Food and Drug Administration is planning to review the cardiovascular risks of attention-deficit hyperactivity disorder treatments, and has...
Adderall
